DOĞAL KRONİK FASCİOLA HEPATICA'IA KOYUNLARDA SERUM SIALIK ASİT SERUM LİPİD-BAĞLI SIALIK ASİT DÜZEYLERİ
Kronik Fasciolazis'li koyunlarda karaciğerde meydana gelen dejenerasyon ve fonksiyonel bozuklukların tespitinde prognoz bakımından hematolojik ve bazı serum biyokimyasal parametrelerinin yanında sialic asit ve lipid-bağlı sialik asit düzeylerinin önemini ortaya koymak için yapıldı. Çalışmada 12'si kronik doğal Fasciola hepatica’ lı ve 10 sağlıklı olmak üzere toplam 22 koyun kullanıldı. Yapılan istatistiksel analizlerde, çalışmanın başlamcm O.günde kronik Fasciolazis'li koyunların değerleri kontrol grubun değerleri karşılaştırıldığında Hct p
SERUM SIALIC ACID, LİPİD-BOUND SIALIC ACID LEVELS IN SHEEP NATURALLY CHRONIC INFECTED WITH FASCIOLA HEPATİCA
The aim of this study to show the importance of sialic acid and lipid-bound sialic acid levels besides some hematological and biochemical parameters with respect to prognosis in detecting the degeneration and functional disorders in the livers of sheep with chronic fascioliasis. This study was carried out on twenty-two female Akkaraman sheep consisting of 10 healthy sheep and 12 sheep naturally chronic infectedwith Fasciola hepatica. In the statistical analyses, in the beginning of the study day 0. , levels of sheep with chronic fascioliasis were compared with the control group levels, a signifîcant decrease was observed in the Hct p
___
- 1. Anderson PH, BerrettS, BrushPJ,Hebert CN, Parfıtt
JW, Patterson DS:. Biochemical indicators of liver injury
in calves with experimental fascioliasis. Vet Rec. 15:43-
45,(1977).
- 2. Sykes AR, Coop RL, Robinson MG: Chronic şubelin ical
ovine fascioliasis: plasma glutamate dehydrogenase,
gamma-glutamyl transpeptidase and aspartate aminotransferase activities and their significance as
diagnosticaids. ResVetSci 28:71-75(1980).
- 3. Bhavanandan VP, Sheykhnazari M: Adaptation of the
periodateresorcinol method for detennination of sialic
acids to a mieroassay using mierotiter plate reader. Anal
Biochem. 213: 438-440(1993).
- 4. Schauer R: Achievements and challenges of sialic acid
researeh. J. Glycoconj. 17:485-499,(2000).
- 5. Tewarson SL, Mittal VP, Singh M. Gupta GP: Serum sialic
acid- an important cancer marker. J. Indian Cancer.
30:125131,(1993).
- 6. Romppanen J: Serum Sialic Acid in Clinical Diagnostics,
Kuopio Unyversity Publications D. Medical Sciences
309, Doctoral dissertation (2003).
- 7. Shamberger RJ: Serum sialic acid in normals and in cancer
patients. J Clin Chem Clin Biochem. 22: 647-651,
(1984).
- 8. Romppanen J, Petâjâ J, Heikinheimo M, Monoııen I:
Total and lipid-bound serum sialic acid in children with
malignaney or infeetions. Anticancer Res. 18:
27932798,(1998).
- 9. O’Kennedy R, Bems G, Moran E, Smyth H, Carroll K,
Thomes RD, O’Brien A, Fennelly J, Butler M: A critical
analysis of the use of sialic acid determination in the
diagnosis of malignaney. Cancer Lett. 58:91- 100,(1991).
- 10. Seider A, Graf N, Sitzmann F: Wertigkeit der
Sialinsâurebestimmung im Serum bei Kindem,
PâdiatrPadol. 27: 4346,(1992).
- 11. Doğan H, Pasaoglu H, Ekinciler OF, Tatlisen N : A
comparative study of total protein, total and
lipidassociated serum sialic acid levels in patients with
Behcet’s disease and control groups. Açta ophthalmol
Copenh. 70: 790794, (1992).
- 12. Allain P, Oliver E, Le-Bouil A, Benoit C, Geslin P, Tadei
A: Increase of sialic acid concentration in the plasma
ofpatients withcoronary disease. Presse Med 25:96-
98,(1996).
- 13. Vural P, Akgul C, Canbaz M: Alterations of total and
lipid-bound sialic acid levels inrecurrent abortion. Int J
Fertil Womens Med. 46:315-319, (2001).
- 14. Boch J, Supperer R: Veterinârmedizinische Parasitologie.
3. AufL Paul Parey Verlag, Berlin und Hamburg. (1983).
- 15. Happic FA, Boray JC: Quantitative diagnosis of chronic
fasciolosis. 1. Comparative studies on quantitative feacel
examinations for chronic Fasciola hepatica
infectioninsheep. AustVet J 45: 326-338, (1969).
- 16. Oosthuizen WTJ, Erasmus JB, Boelema E, Grove JT:
Efficacy of moxidectin against internal parasites of
sheep. JSAffVetAss 64: 28-30.(1993).
- 17. Dedie K, Bostedt H: Schafkrankheiten. Ulmer Verlag,
Stuttgart(1985).
- 18. Zimmerman GL: Liver flukes in ruminants. In Large
animal internal medicine. Ed. Smith, B. Mosby Publ., St.
louis, Baltimore, Philadelphia, Toronto. (1989).
- 19. Jain NC: The deer. In: Schalm's Veterinary Haematology,
5th ed., Shalm, O.W., Jain, N.C., Carol, E.J. Eds., Lea
and Febiger, Philadelphia. (1986).
- 20. Katopodis N, Hirshaut Y, Geller NL, Stock CC: Lipid
associated sialic acid test for the deteetion of human
cancer. CancerRes 42: 5270-5275,(1982).
- 21. Sydow GA: Simplifîed quick method for determination of
sialic acid in serum. Biomed. Biochem. Açta. 44: 1721-
1723, (1985).
- 22. Spithill TW, Dalton JP: Progress in development of liver
fluke vaccines.ParasitolToday. 14: 224228,(1998).
- 23. Dalton JP: Epidemiology and control. In: Dalton, J.P.:
Fasciolosis. CABI Publishing, Cambridge, pp 113-
149.(1999).
- 24. Marques SMT, Scrofemeker ML: Fasciola hepatica
infeetion in cattle and buffaloes in the State of Rio
Grande do Sul, Brazil. Parasitol. Latinoam. 58: 169-
172,(2003).
- 25. Benchaoui HA, McKellar QA: Effect of early treatment
with rafoxanide on antipyrine clearance in sheep infected
with Fasciola hepatica. Xenobiotica. 23: 439448,(1993).
- 26. Ferre I, Lopez P, Rojo-Vazquez FA, Gonzalez-Gallego
J: Experimental ovine fasciolosis: antipyrine clearance as
indicator of liver damage. Vet. Parasitol 62:93-100,
(1996).
- 27. Galtier P, Larrieu G, Tufenkji AE, Franc M: Influence of
experimental fascioliasis on the activity of drugmetabolizing enzvmes in lamb liver. Drug Metab Dispos
14:137141. (1986)
- 28. Ferre I, Lopez P, Gonzalo-Orden M, Julian MD, Rojo
FA, Gonza' lez-Gallego J: The effects of subclinical
fascioliasis on hepatic secretory funetion in sheep.
ParasitolRe 81:127131, (1995).
- 29. Kouider S, Kolb E: Der Gehalt an Ascorbinsaure, an
glucose, an gesampprotein, an AL AT und an ASAT im
blutplasma von gesunden sehafen sowie bei solehen mit
parasitenbefall vor und nach i.v. injektion von
ascorbinsaurelosung. Monatshefte-für- Veterinarmedizin.
49: 135-141,(1994).
- 30. Bain PJ: Liver. In: Latimer KS, Mahaffey EA, Prasse
KW, Duncan and Prasse's Veterinary Laboratory
Medicine: Clinical Pathology, 4th ed. Ames, Iowa State
Press, 193-214,(2003),
- 31. Stockham SL, Scott MA: Fundamentals of Veterinary
Clinical Pathology. Ames, Iowa State Press, 43 8: 446-
450.2002
- 32. TimoteoOV, Maco JV, V. Maco PJ, NeyraGY, Leguı'a
JR: Espinoza Characterization of the humoral immune
response in alpacas (Lama pacos) experimentally
infected with Fasciola hepatica against eysteine
proteinases Fasl and Fas2 and histopathological findings.
Veterinary Immunology and Immunopathology 106:
7786.(2005).
- 33. Mitruka B M, Rawnsley HM: Clinical biochemical and
hematological reference values in normal experimental
animals and normal humans. 2nd Ed., Year Book
Medical Publishers Inc., Chicago, (1981).
- 34. Chauvin A, Bouvet G, Boulard C : Humoral and cellular
immune responses to Fasciola hepatica experimental
primary and secondary infection in sheep. Int J
Parasitol.25:12271241,(1995).
- 35. Conboy GA, Stromberg BE: Hematology and clinical
pathology of experimental Fascioloides magna infection
in cattle and guinea pigs. Veterinary Parasitology.
40:241-255(1991).
- 36. Hawkins CD: The use of hemoglobin, packed-cell volüme
and serum sorbitol dehydrogenase as indicators of the development of fascioliasis in sheep. Vet Parasitol
15:125-133, (1984).
- 37. Presidente PJ, McCraw BM, Lumsden JH:
Experimentally induced Fasciola hepatica infection in
white-tailed deer. I. Clinicopathological and
parasitological features, Can J Comp Med. 39: 155-
165,(1975).
- 38. Crook MA, Haq M, Tutt P: Serum sialic acid and its
relationship to various haematological parameters,
including erythrocyte sedimentatıon rate. Br J Biomed
Sci. 54:100-103, (1997).
- 39. Blood DC, Radostits DM, Henderson JA: Veterinary
Medicine, 7th Ed., Bailiere Tindall, London. (1987).
- 40. Degheidy NS, Amin MM, Ghazy AA: Effect of
fasciolosis on liver function before and after treatment in
sheep. Egyptian Journal of Comparative Pathology and
Clinical Pathology. 1: 65-76, (1990).
- 41. Swarup D, Upadhyay DS, Pachauri SP: Some
biochemical indices in naturally occurring fascioliasis
ingoats. Res VetSci 40:276-277, (1986).
- 42. Kokoglu E, Sönmez H, Uslu E, Uslu I: Sialic acid levels
in various types of cancer, Cancer Biochem Biophys.
13:57-64, (1992).
- 43. Polivkova J, Vosmikova K, Horak L : Utilization of
detemıining lipid-bound sialic acid for the diagnosis and
furtherprognosis ofcancer. Neoplasma. 39:233-
236,(1992).
- 44. Pönniö M, Alho H, Heinalâ P, Nikkari ST, Sillanaukee P:
Serum and saliva levels of sialic acid are elevated in
alcoholics. Alcohol Clin. Exp. Res. 23: 10601064,
(1999).
- 45. Lindberg G, Eklund GA, Gullberg B, Rastam L: Serum
sialic acid concentration and cardiovascular mortality.
JBiolMed302:143-146,(1991).
- 46. Crook MA, Tutt P, Pickup JC: Elevated serum sialic acid
concentration in NIDDM and its relationship to blood
pressure and retinopathy. Diabetes Çare. 16: 57-60,
(1993).
- 47. Kongtawelert P, Tangkijvanich P, Ong-Chai S,
Poovorawan Y: Role of serum total sialic acid in
differentiating cholangiocarcinoma from hepatocellular
carcinoma. J World Gastroenterol 9: 2178-2181,(2003).
- 48. VanDijkW, PosO, Van der Stelt ME, Moshage HJ, Yap
SH, Dente L, Baumann P, Eap CB: Inflammationinduced changes in expression and glycosylation of
genetic variants of alpha 1-acidglycoprotein. Studies with
human sera, primary cultures of human hepatocytes and
transgenic mice. J Biochem 276: 343-347,(1991).
- 49. Crook MA, Treloar A, Haq M, Tutt P: Serum total sialic
acid and acute phase proteins in elderly subjects. Eur J
Clin Chem Clin Biochem. 32:745-747, (1994).
- 50. Taniuchi K, Chifu K, Hayashi NA: New enzymatic
method for the determination of sialic acid in serum and
its application for a marker of acute phase reactants. J
KobeMed.Sci.27:91-102,(1981).
- 51. Murray RK, Granner DK, May es PA, Rodwell VW: Lipid
transport and storage. In: Harper’s biochemistry, 23rd ed.
Norwalk, Conn: Appleton & Lange. 250-258, (1993).
- 52. Schutter EMJ, Visser JJ, Van Kamp GJ, MensdorffPouilly S, van Dijk W, Hilgers J, Kenemans P: The
utility of lipid-associated sialic acid (LASA or LSA) as a
serum marker for malignancy. A review of the literatüre.
TumourBiol. 13:121-132,(1992).
- 53. Vardi J, Tadros GH, Foemmel R, Shebes M: Plasma
lipidassociated sialic acid and serum CA 125 as
indicators of disease status with advanced ovarian cancer.
ObstetGynecol., 74:379-383, (1989).
- 54. Ropka ME, Goodwin WJ, Levine PA, Sasaki CT,
Kirchner JC, Cantrell RW: Effective head and neck
tumor markers. The continuing quest. Arch Otolaryngol
Head Neck Surg. 117:101114,(1991).